Autres langues

18/09/25 Y-mAbs Therapeutics, Inc.(NasdaqGS:YMAB) dropped from Russell Microcap Index
18/09/25 Y-mAbs Therapeutics, Inc.(NasdaqGS:YMAB) dropped from Russell 3000E Index
18/09/25 Y-mAbs Therapeutics, Inc.(NasdaqGS:YMAB) dropped from Russell 3000E Growth Index
18/09/25 Y-mAbs Therapeutics, Inc.(NasdaqGS:YMAB) dropped from Russell Microcap Growth Index
18/09/25 Y-mAbs Therapeutics, Inc.(NasdaqGS:YMAB) dropped from Russell 2000 Index
18/09/25 Y-mAbs Therapeutics, Inc.(NasdaqGS:YMAB) dropped from Russell Small Cap Comp Growth Benchmark
18/09/25 Y-mAbs Therapeutics, Inc.(NasdaqGS:YMAB) dropped from Russell Microcap Growth Benchmark Index
18/09/25 Y-mAbs Therapeutics, Inc.(NasdaqGS:YMAB) dropped from Russell 3000E Growth Benchmark
18/09/25 Y-mAbs Therapeutics, Inc.(NasdaqGS:YMAB) dropped from Russell 3000 Growth Benchmark
18/09/25 Y-mAbs Therapeutics, Inc.(NasdaqGS:YMAB) dropped from Russell 2500 Growth Benchmark
18/09/25 Y-mAbs Therapeutics, Inc.(NasdaqGS:YMAB) dropped from Russell 2000 Growth Benchmark
18/09/25 Y-mAbs Therapeutics, Inc.(NasdaqGS:YMAB) dropped from Russell 2500 Growth-Dynamic Index
18/09/25 Y-mAbs Therapeutics, Inc.(NasdaqGS:YMAB) dropped from Russell 2000 Growth-Dynamic Index
18/09/25 Y-mAbs Therapeutics, Inc.(NasdaqGS:YMAB) dropped from Russell 2500 Dynamic Index
18/09/25 Y-mAbs Therapeutics, Inc.(NasdaqGS:YMAB) dropped from Russell 2000 Dynamic Index
18/09/25 Y-mAbs Therapeutics, Inc.(NasdaqGS:YMAB) dropped from Russell 2500 Growth Index
18/09/25 Y-mAbs Therapeutics, Inc.(NasdaqGS:YMAB) dropped from Russell 3000 Growth Index
18/09/25 Y-mAbs Therapeutics, Inc.(NasdaqGS:YMAB) dropped from Russell Small Cap Comp Growth Index
18/09/25 Y-mAbs Therapeutics, Inc.(NasdaqGS:YMAB) dropped from Russell Small Cap Completeness Index
18/09/25 Y-mAbs Therapeutics, Inc.(NasdaqGS:YMAB) dropped from Russell 2000 Growth Index
18/09/25 Y-mAbs Therapeutics, Inc.(NasdaqGS:YMAB) dropped from Russell 3000 Index
18/09/25 Y-mAbs Therapeutics, Inc.(NasdaqGS:YMAB) dropped from Russell 2500 Index
16/09/25 Y-Mabs Therapeutics, Inc. Announces Resignation of Peter Pfreundschuh as Chief Financial Officer, Effective September 16, 2025
16/09/25 Y-Mabs Therapeutics, Inc. Announces Board and Committee Changes
16/09/25 Y-Mabs Therapeutics, Inc. Announces Resignation of Michael Rossi as Chief Executive Officer, Effective September 16, 2025
Aucun résultat pour cette recherche